Cybin Cybin is a biopharmaceutical company that focuses on developing psychedelic-based therapeutics. | ||
Founding Date | Founding Date 2019 | Founding Date 1915 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Toronto, CA HQ Dublin, IE | Locations København, DK HQ Buenos Aires, AR North Ryde, AU Wien, AT Bruxelles, BE Rio De Janeiro, BR Sofia, BG see more |
Employees | Employees 50 | Employees 5,700 |
Valuation ($) | Valuation ($) 209.9 m | Valuation ($) 6.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr24.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods kr2.7b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit kr22b (FY, 2025) |
Net income | Net income ($113.1m) (FY, 2025) | Net income kr3.2b (FY, 2025) |
Operating ⚠ | ||
Trademarks | Trademarks 24 (FY, 2023) | Trademarks 2.7 k (May, 2024) |

H. Lundbeck is a pharmaceutical company specializing in brain diseases.
View company